| Literature DB >> 30783134 |
Qi Wang1,2,3, Xu-Li Tang4, Xiang-Chao Luo1,2, Nicole J de Voog5, Ping-Lin Li6,7, Guo-Qiang Li8,9.
Abstract
Seven pairs of new oxygenated aplysinopsin-type enantiomers, (+)- and (-)-oxoaplysinopsins A‒G (1‒7), two new bromotyrosine-derived alkaloids, subereamollines C and D (18 and 19), together with ten known compounds (8‒17) were isolated from the Xisha Islands sponge Fascaplysinopsis reticulata. The planar structures were determined by extensive NMR and MS spectroscopic data. Each of the optically pure enantiomers was achieved by chiral HPLC separation. The absolute configurations were assigned by the quantum chemical calculation methods. Compound 19 showed cytotoxicity against Jurkat cell lines with IC50 value of 0.88 μM. Compounds 2, 16 and 17 showed tyrosine phosphatase 1B (PTP1B) inhibition activity with IC50 value ranging from 7.67 to 26.5 μM, stronger than the positive control of acarbose and 1-deoxynojirimycin. A structural activity relationship for the aplysinopsin-type enantiomers were observed in PTP1B inhibition activity of 2 and cytotoxicity of 3 that the dextrorotary (+)-2 and (+)-3 showed stronger activity than the levorotary (-)-2 and (-)-3.Entities:
Year: 2019 PMID: 30783134 PMCID: PMC6381124 DOI: 10.1038/s41598-019-38696-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Structures of 1–19 from sponge Fascaplysinopsis reticulata.
1H (500 MHz) and 13C NMR (125 MHz) Data for 1–3 and 6 in DMSO-d6.
| No | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
| 1 | 10.30, br s | 10.43, br s | 10.30, br s | |||
| 2 | 176.2, C | 175.3, C | 177.9, C | |||
| 3 | 74.9, C | 76.2, C | 72.3, C | |||
| 3a | 132.1, C | 126.9, C | 128.6, C | |||
| 4 | 123.9, CH | 7.16, d, 1 H (6.7) | 124.1, CH | 7.08, d, 1 H (7.5) | 126.3, CH | 7.04, d, 1 H (7.4) |
| 5 | 121.4, CH | 6.88, dd, 1 H (7.5, 7.5) | 121.5, CH | 6.90, dd, 1 H (7.5, 7.5) | 120.9, CH | 6.88, dd, 1 H (7.5, 7.5) |
| 6 | 129.2, CH | 7.18, dd, 1 H (7.7, 6.2) | 130.1, CH | 7.22, dd, 1 H (7.7, 7.7) | 129.4, CH | 7.13, dd, 1 H (7.5, 7.6) |
| 7 | 109.4, CH | 6.80, d, 1 H (7.6) | 109.9, CH | 6.78, d, 1 H (7.7) | 109.2, CH | 6.70, d, 1 H (7.5) |
| 7a | 143.0, C | 142.6, C | 142.3, C | |||
| 8 | 117.5, CH | 5.80, s, 1 H | 41.7, CH2 | 2.57, s, 2 H | ||
| 1′ | 130.4, C | 66.1, CH | 4.40, s, 1 H | 83.4, C | ||
| 3′ | 153.3, C | 157.2, C | 155.6, C | |||
| 5′ | 161.3, C | 168.6, C | 172.3, C | |||
| 2′-NCH3 | 26.1, CH3 | 3.04, s, 3 H | 31.3, CH3 | 3.14, s, 3 H | 24.4, CH3 | 2.55, s, 3 H |
| 4′-NCH3 | 24.4, CH3 | 2.83, s, 3 H | 24.2, CH3 | 2.50, s, 3 H | 23.7, CH3 | 2.19, s, 3 H |
| 3-OH | 6.85, s | 6.62, s | 6.70, s | |||
| 1′-OH | 6.00, s | |||||
Figure 2Key COSY and HMBC correlations in compounds 1–4, and 18.
1H (500 MHz) and 13C NMR (125 MHz) Data for 4–5 in DMSO-d6.
| No | 4 | 5 | 6 | 7 | ||||
|---|---|---|---|---|---|---|---|---|
| 1 | 11.13, br s | 11.18, br s | 11.17, br s | 11.20, br s | ||||
| 2 | 124.6, CH | 7.15, d, 1 H (2.3) | 124.7, CH | 7.17, d, 1 H (2.2) | 125.3, CH | 7.28, s, 1 H | 125.8, C | 7.29, s |
| 3 | 108.5, C | 107.9, C | 108.3, C | 108.4, C | ||||
| 3a | 127.0, C | 127.0, C | 126.5, C | 126.8, C | ||||
| 4 | 119.0, CH | 7.54, d, 1 H (8.0) | 118.9, CH | 7.53, d, 1 H (8.0) | 120.2, CH | 7.62, d, 1 H (8.0) | 120.4, CH | 7.58, d, 1 H (8.0) |
| 5 | 118.7, CH | 6.97, dd, 1 H (8.0, 8.0) | 118.8, CH | 6.97, dd, 1 H (7.8, 7.2) | 118.9, CH | 6.98, dd, 1 H (7.5, 7.5) | 119.5, CH | 7.00, dd, 1 H (7.3, 7.7) |
| 6 | 120.9, CH | 7.05, dd, 1 H (7.2, 7.8) | 120.9, CH | 7.06, dd, 1 H (7.2, 7.9) | 121.0, CH | 7.07, dd, 1 H (7.3, 7.7) | 121.5, CH | 7.08, dd, 1 H (7.2, 7.9) |
| 7 | 111.4, CH | 7.34, d, 1 H (8.1) | 111.4, CH | 7.35, d, 1 H (8.1) | 111.5, CH | 7.36, d, 1 H (8.1) | 112.1, CH | 7.37, d, 1 H (8.1) |
| 7a | 135.7, C | 135.7, C | 136.3, C | 136.8, C | ||||
| 8 | 78.7, CH | 4.88, s, 1 H | 77.9, CH | 4.94, s, 1 H | 79.2, CH | 4.78, s, 1 H | 79.4, CH | 4.85, s, 1 H |
| 1′ | 87.4, C | 92.4, C | 86.8, C | 92.3, C | ||||
| 3′ | 155.6, C | 155.6, C | 156.6, C | 156.6, C | ||||
| 5′ | 171.8, C | 169.2, C | 173.7, C | 171.4, C | ||||
| 2′-NCH3 | 25.5, CH3 | 3.00, s, 3 H | 25.6, CH3 | 3.02, s, 3 H | 25.6, CH3 | 2.22, s, 3 H | 26.1, CH3 | 2.33, s, 3 H |
| 4′-NCH3 | 23.9, CH3 | 2.54, s, 3 H | 23.9, CH3 | 2.60, s, 3 H | 24.2, CH3 | 2.86, s, 3 H | 24.7, CH3 | 2.90, s, 3 H |
| 8-OCH3 | 57.3, CH3 | 3.20, s, 3 H | 57.1, CH3 | 3.19, s, 3 H | 57.0, CH3 | 3.18, s, 3 H | 57.6, CH3 | 3.19, s, 3 H |
| 1′-OH | 6.96, s | 6.94, s | ||||||
| 1′-OCH3 | 51.3, CH3 | 3.03, s, 3 H | 51.8, CH3 | 3.01, s, 3 H | ||||
Figure 3(A) Experimental ECD spectra of (+)- and (−)-1 in MeOH and calculated ECD spectra of (3R)-1 and (3S)-1 (half width 0.3; UV-shift 5 nm). (B) Experimental ECD spectra of (+)- and (−)-2 in MeOH and calculated ECD spectra of (3R, 1′R)-2 and (3S, 1′S)-2 (half width 0.24; UV-shift -18 nm).(C) Experimental ECD spectra of (+)- and (−)-2 in MeOH and calculated ECD spectra of (3R, 1′S)-2 and (3S, 1′R)-2 (half width 0.24; UV-shift 0 nm). (D) Experimental ECD spectra of (+)- and (−)-3 in MeOH and calculated ECD spectra of (3R, 1′R)-3 and (3S, 1′S)-3 (half width 0.2; UV-shift 10 nm). (E) Experimental ECD spectra of (+)- and (−)-3 in MeOH and calculated ECD spectra of (3R, 1′S)-3 and (3S, 1′R)-3 (half width 0.2; UV-shift 10 nm). (F) Experimental ECD spectra of (+)- and (−)-5 in MeOH and calculated ECD spectra of (8R, 1′R)-5 and (8S, 1′S)-5 (half width 0.44; UV-shift 0 nm). (G) Experimental ECD spectra of (+)- and (−)-5 in MeOH and calculated ECD spectra of (8R, 1′S)-5 and (8S, 1′R)-5 (half width 0.44; UV-shift 0 nm).(H) Experimental ECD spectra of (+)- and (−)-7 in MeOH and calculated ECD spectra of (8S, 1′R)-7 and (8R, 1′S)-7 (half width 0.16; UV-shift -20 nm). (I) Experimental ECD spectra of (+)- and (−)-7 in MeOH and calculated ECD spectra of (8R, 1′R)-7 and (8S, 1′S)-7 (half width 0.16; UV-shift -20 nm). (J) Experimental ECD spectra of 18 in MeOH and calculated ECD spectra of (1R, 6′S)-18a,(1S, 6′R)-18a,(1R, 6′R)-18a, and (1S, 6′S)-18a (half width 0.5; UV-shift: -13 nm).
1H (500 MHz) and 13C NMR (125 MHz) Data for 18 and 19 in DMSO-d6.
| No | 18 | 19 | ||
|---|---|---|---|---|
| 1 | 73.6, CH | 3.91, d, 1 H (5.6) | 73.6, CH | 3.91, d, 1 H (5.6) |
| 2 | 113.1, C | 113.1, C | ||
| 3 | 147.1, C | 147.1, C | ||
| 4 | 120.8, C | 120.8, C | ||
| 5 | 131.3, CH | 6.58, s, 1 H | 131.3, CH | 6.59, s, 1 H |
| 6 | 90.1, C | 90.1, C | ||
| 7 | 39.4, CH2 | 3.61, d, 1 H (18.2); 3.20 d, 1 H (18.2) | 39.4, CH2 | 3.61, d, 1 H (18.3); 3.21, d, 1 H (18.3) |
| 8 | 154.5, C | 154.1, C | ||
| 9 | 158.8, C | 158.8, C | ||
| 10 | 8.49, t (5.7, 5.8) | 8.52, t (5.5, 5.6) | ||
| 11 | 38.5, CH2 | 3.13, m, 2 H | 38.7, CH2 | 3.11, m, 2 H |
| 12 | 26.2, CH2 | 1.43, m, 2 H | 29.1, CH2 | 1.44, m, 2 H |
| 13 | 26.9, CH2 | 1.38, m, 2 H | 23.6, CH2 | 1.23, m, 2 H |
| 14 | 39.9, CH2 | 2.96, m, 2 H | 28.5, CH2 | 1.38, m, 2 H |
| 15 | 7.08, t (4.9, 4.9) | 40.1, CH2 | 2.94, m, 2 H | |
| 16 | 156.7, C | 7.11, t (5.5, 5.5) | ||
| 17 | 156.7, C | |||
| 1-OH | 6.36, d (7.1) | 6.39, d (7.1) | ||
| 3-OCH3 | 59.6, CH3 | 3.65, s, 3 H | 59.6, CH3 | 3.64, s, 3 H |
| 16-OCH3 | 51.1, CH3 | 3.50, s, 3 H | ||
| 17-OCH3 | 51.5, CH3 | 3.50, s, 3 H | ||